![](/img/cover-not-exists.png)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M Ridker, Eleanor Danielson, Francisco AH Fonseca, Jacques Genest, Antonio M Gotto Jr, John JP Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen, Børge G NordestgaarVolume:
373
Year:
2009
Language:
english
DOI:
10.1016/s0140-6736(09)60447-5
File:
PDF, 212 KB
english, 2009